Insurance - Brokers
Compare Stocks
2 / 10Stock Comparison
ARX vs RYAN
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
ARX vs RYAN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Insurance - Brokers | Insurance - Specialty |
| Market Cap | $1.45B | $4.11B |
| Revenue (TTM) | $796M | $3.16B |
| Net Income (TTM) | $-1.43B | $132M |
| Gross Margin | 67.1% | 69.4% |
| Operating Margin | -166.0% | 16.6% |
| Forward P/E | 19.9x | 14.9x |
| Total Debt | $121M | $3.53B |
| Cash & Equiv. | $1.80B | $158M |
Quick Verdict: ARX vs RYAN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ARX is the clearest fit if your priority is value and momentum.
- Better valuation composite
- -48.8% vs RYAN's -54.6%
RYAN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.23, yield 0.7%
- Rev growth 21.3%, EPS growth -33.8%, 3Y rev CAGR 20.9%
- 20.0% 10Y total return vs ARX's -48.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.3% revenue growth vs ARX's -11.6% | |
| Value | Better valuation composite | |
| Quality / Margins | Combined ratio 0.8 vs ARX's 3.6 (lower = better underwriting) | |
| Stability / Safety | Beta 0.23 vs ARX's 0.44 | |
| Dividends | 0.7% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | -48.8% vs RYAN's -54.6% | |
| Efficiency (ROA) | 1.3% ROA vs ARX's -18.8% |
ARX vs RYAN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ARX vs RYAN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
RYAN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RYAN is the larger business by revenue, generating $3.2B annually — 4.0x ARX's $796M. RYAN is the more profitable business, keeping 4.2% of every revenue dollar as net income compared to ARX's -179.0%. On growth, RYAN holds the edge at +15.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $796M | $3.2B |
| EBITDAEarnings before interest/tax | -$1.3B | $743M |
| Net IncomeAfter-tax profit | -$1.4B | $132M |
| Free Cash FlowCash after capex | $445M | $555M |
| Gross MarginGross profit ÷ Revenue | +67.1% | +69.4% |
| Operating MarginEBIT ÷ Revenue | -166.0% | +16.6% |
| Net MarginNet income ÷ Revenue | -179.0% | +4.2% |
| FCF MarginFCF ÷ Revenue | +55.9% | +17.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -15.0% | +15.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +2.4% |
Valuation Metrics
ARX leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.5B | $4.1B |
| Enterprise ValueMkt cap + debt − cash | -$224M | $7.5B |
| Trailing P/EPrice ÷ TTM EPS | -1.81x | 67.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.92x | 14.90x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 8.20x |
| Price / SalesMarket cap ÷ Revenue | 2.81x | 1.35x |
| Price / BookPrice ÷ Book value/share | 3.55x | 7.04x |
| Price / FCFMarket cap ÷ FCF | 3.27x | 7.14x |
Profitability & Efficiency
RYAN leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
RYAN delivers a 10.8% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-2 for ARX. ARX carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to RYAN's 2.82x. On the Piotroski fundamental quality scale (0–9), RYAN scores 6/9 vs ARX's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -2.5% | +10.8% |
| ROA (TTM)Return on assets | -18.8% | +1.3% |
| ROICReturn on invested capital | — | +10.8% |
| ROCEReturn on capital employed | -18.4% | +6.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.17x | 2.82x |
| Net DebtTotal debt minus cash | -$1.7B | $3.4B |
| Cash & Equiv.Liquid assets | $1.8B | $158M |
| Total DebtShort + long-term debt | $121M | $3.5B |
| Interest CoverageEBIT ÷ Interest expense | 0.05x | 2.29x |
Total Returns (Dividends Reinvested)
RYAN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RYAN five years ago would be worth $12,000 today (with dividends reinvested), compared to $5,117 for ARX. Over the past 12 months, ARX leads with a -48.8% total return vs RYAN's -54.6%. The 3-year compound annual growth rate (CAGR) favors RYAN at -8.6% vs ARX's -20.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -13.1% | -37.1% |
| 1-Year ReturnPast 12 months | -48.8% | -54.6% |
| 3-Year ReturnCumulative with dividends | -48.8% | -23.8% |
| 5-Year ReturnCumulative with dividends | -48.8% | +20.0% |
| 10-Year ReturnCumulative with dividends | -48.8% | +20.0% |
| CAGR (3Y)Annualised 3-year return | -20.0% | -8.6% |
Risk & Volatility
RYAN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
RYAN is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than ARX's 0.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.44x | 0.23x |
| 52-Week HighHighest price in past year | $31.18 | $72.50 |
| 52-Week LowLowest price in past year | $9.18 | $29.28 |
| % of 52W HighCurrent price vs 52-week peak | +43.5% | +43.8% |
| RSI (14)Momentum oscillator 0–100 | 45.5 | 28.8 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 2.1M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ARX as "Buy" and RYAN as "Buy". Consensus price targets imply 43.8% upside for RYAN (target: $46) vs 22.4% for ARX (target: $17). RYAN is the only dividend payer here at 0.71% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $16.60 | $45.60 |
| # AnalystsCovering analysts | 9 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | +0.7% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.22 |
| Buyback YieldShare repurchases ÷ mkt cap | +12.1% | +0.1% |
RYAN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARX leads in 1 (Valuation Metrics).
ARX vs RYAN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ARX or RYAN a better buy right now?
For growth investors, Ryan Specialty Holdings, Inc.
(RYAN) is the stronger pick with 21. 3% revenue growth year-over-year, versus -11. 6% for Accelerant Holdings (ARX). Ryan Specialty Holdings, Inc. (RYAN) offers the better valuation at 67. 5x trailing P/E (14. 9x forward), making it the more compelling value choice. Analysts rate Accelerant Holdings (ARX) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ARX or RYAN?
On forward P/E, Ryan Specialty Holdings, Inc.
is actually cheaper at 14. 9x.
03Which is the better long-term investment — ARX or RYAN?
Over the past 5 years, Ryan Specialty Holdings, Inc.
(RYAN) delivered a total return of +20. 0%, compared to -48. 8% for Accelerant Holdings (ARX). Over 10 years, the gap is even starker: RYAN returned +20. 0% versus ARX's -48. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ARX or RYAN?
By beta (market sensitivity over 5 years), Ryan Specialty Holdings, Inc.
(RYAN) is the lower-risk stock at 0. 23β versus Accelerant Holdings's 0. 44β — meaning ARX is approximately 89% more volatile than RYAN relative to the S&P 500. On balance sheet safety, Accelerant Holdings (ARX) carries a lower debt/equity ratio of 17% versus 3% for Ryan Specialty Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ARX or RYAN?
By revenue growth (latest reported year), Ryan Specialty Holdings, Inc.
(RYAN) is pulling ahead at 21. 3% versus -11. 6% for Accelerant Holdings (ARX). On earnings-per-share growth, the picture is similar: Ryan Specialty Holdings, Inc. grew EPS -33. 8% year-over-year, compared to -54. 5% for Accelerant Holdings. Over a 3-year CAGR, ARX leads at 34. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ARX or RYAN?
Ryan Specialty Holdings, Inc.
(RYAN) is the more profitable company, earning 2. 1% net margin versus -275. 8% for Accelerant Holdings — meaning it keeps 2. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RYAN leads at 20. 5% versus -255. 8% for ARX. At the gross margin level — before operating expenses — RYAN leads at 90. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ARX or RYAN more undervalued right now?
On forward earnings alone, Ryan Specialty Holdings, Inc.
(RYAN) trades at 14. 9x forward P/E versus 19. 9x for Accelerant Holdings — 5. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RYAN: 43. 8% to $45. 60.
08Which pays a better dividend — ARX or RYAN?
In this comparison, RYAN (0.
7% yield) pays a dividend. ARX does not pay a meaningful dividend and should not be held primarily for income.
09Is ARX or RYAN better for a retirement portfolio?
For long-horizon retirement investors, Ryan Specialty Holdings, Inc.
(RYAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 0. 7% yield). Both have compounded well over 10 years (RYAN: +20. 0%, ARX: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ARX and RYAN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ARX is a small-cap quality compounder stock; RYAN is a small-cap high-growth stock. RYAN pays a dividend while ARX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.